(Q77622160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Response rate as an endpoint for evaluating new cytotoxic agents in phase II trials of non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

phase II clinical trial

1 reference

I Sekine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K Kubota

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Y Nishiwaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Y Sasaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

T Tamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

N Saijo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1079-1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

A phase II study of high dose epirubicin in unresectable non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Ifosfamide in the treatment of recurrent or disseminated lung cancerA phase II study of two dose schedules

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

New agents in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Why does a higher response rate to chemotherapy correlate poorly with improved survival?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

A call for change in anticancer drug evaluation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Anticancer drug evaluation: continuing progress from existing methodology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Surrogate markers in AIDS and cancer trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Surrogate endpoints in clinical trials: cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008473003445

7 January 2021

Identifiers

DOI

10.1023/A:1008473003445

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9834819%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference